HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Uterine Cancer

Uterine Cancer

Uterine cancer, predominantly affecting the lining of the uterus, poses significant health challenges for women worldwide. Research in this field encompasses various aspects, from understanding the genetic predispositions to exploring novel treatment modalities. Recent strides in cancer research have uncovered potential biomarkers for early detection and personalized therapies, promising improved outcomes. Additionally, studies focus on elucidating the interplay between hormones, lifestyle factors, and uterine cancer risk, aiding in prevention strategies. Furthermore, innovative immunotherapies and targeted drugs offer hope for advanced-stage patients. Collaborative efforts among researchers, clinicians, and advocates drive progress, emphasizing the importance of early diagnosis, risk assessment, and comprehensive care in combating uterine cancer's burden on women's health.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp